000 01490 a2200433 4500
005 20250518052407.0
264 0 _c20200128
008 202001s 0 0 eng d
022 _a1520-5762
024 7 _a10.1080/03639045.2019.1648500
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSalem, Heba F
245 0 0 _aNanosized nasal emulgel of resveratrol: preparation, optimization,
_h[electronic resource]
260 _bDrug development and industrial pharmacy
_cOct 2019
300 _a1624-1634 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Intranasal
_xmethods
650 0 4 _aAnimals
650 0 4 _aBiological Availability
650 0 4 _aChemistry, Pharmaceutical
_xmethods
650 0 4 _aDrug Delivery Systems
_xmethods
650 0 4 _aEmulsions
_xchemistry
650 0 4 _aGels
_xchemistry
650 0 4 _aMale
650 0 4 _aNasal Mucosa
_xmetabolism
650 0 4 _aPoloxamer
_xchemistry
650 0 4 _aPolymers
_xchemistry
650 0 4 _aPolysorbates
_xchemistry
650 0 4 _aPropylene Glycols
_xchemistry
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aResveratrol
_xchemistry
650 0 4 _aSolubility
_xdrug effects
700 1 _aKharshoum, Rasha M
700 1 _aAbou-Taleb, Heba A
700 1 _aNaguib, Demiana M
773 0 _tDrug development and industrial pharmacy
_gvol. 45
_gno. 10
_gp. 1624-1634
856 4 0 _uhttps://doi.org/10.1080/03639045.2019.1648500
_zAvailable from publisher's website
999 _c29948222
_d29948222